These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38424436)

  • 1. Microfluidics-mediated Liposomal Nanoparticles for Cancer Therapy: Recent Developments on Advanced Devices and Technologies.
    Naghib SM; Mohammad-Jafari K
    Curr Top Med Chem; 2024; 24(14):1185-1211. PubMed ID: 38424436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity.
    Gkionis L; Campbell RA; Aojula H; Harris LK; Tirella A
    Int J Pharm; 2020 Nov; 590():119926. PubMed ID: 33010397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics.
    Gkionis L; Aojula H; Harris LK; Tirella A
    Int J Pharm; 2021 Jul; 604():120711. PubMed ID: 34015381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidic methods for production of liposomes.
    Yu B; Lee RJ; Lee LJ
    Methods Enzymol; 2009; 465():129-41. PubMed ID: 19913165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone Loaded Liposomes by Thin-Film Hydration and Microfluidic Procedures: Formulation Challenges.
    Al-Amin MD; Bellato F; Mastrotto F; Garofalo M; Malfanti A; Salmaso S; Caliceti P
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in liposome-based targeted cancer therapy.
    Fidan Y; Muçaj S; Timur SS; Gürsoy RN
    J Liposome Res; 2024 Jun; 34(2):316-334. PubMed ID: 37814217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations.
    Ballacchino G; Weaver E; Mathew E; Dorati R; Genta I; Conti B; Lamprou DA
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidics: a transformational tool for nanomedicine development and production.
    Garg S; Heuck G; Ip S; Ramsay E
    J Drug Target; 2016 Nov; 24(9):821-835. PubMed ID: 27492254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into theranostic nanovesicles prepared by thin lipid hydration and microfluidic method.
    Skupin-Mrugalska P; Zalewski T; Elvang PA; Nowaczyk G; Czajkowski M; Piotrowska-Kempisty H
    Colloids Surf B Biointerfaces; 2021 Sep; 205():111871. PubMed ID: 34051668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel microfluidic swirl mixers for scalable formulation of curcumin loaded liposomes for cancer therapy.
    Xu R; Tomeh MA; Ye S; Zhang P; Lv S; You R; Wang N; Zhao X
    Int J Pharm; 2022 Jun; 622():121857. PubMed ID: 35623489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted liposomal drug delivery: a nanoscience and biophysical perspective.
    Liu Y; Castro Bravo KM; Liu J
    Nanoscale Horiz; 2021 Feb; 6(2):78-94. PubMed ID: 33400747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional vs PEGylated loaded liposomal formulations by microfluidics for delivering hydrophilic chemotherapy.
    Jaradat E; Meziane A; Lamprou DA
    Int J Pharm; 2024 Apr; 655():124077. PubMed ID: 38569975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy.
    Jaradat E; Weaver E; Meziane A; Lamprou DA
    Int J Pharm; 2022 Nov; 628():122320. PubMed ID: 36272514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Progress in Liposome Production, Relevance to Drug Delivery and Nanomedicine.
    Koynova R; Tenchov B
    Recent Pat Nanotechnol; 2015; 9(2):86-93. PubMed ID: 27009123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
    Moosavian SA; Bianconi V; Pirro M; Sahebkar A
    Semin Cancer Biol; 2021 Feb; 69():337-348. PubMed ID: 31585213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates on the use of liposomes for active tumor targeting in cancer therapy.
    Yan W; Leung SS; To KK
    Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic self-assembly of a combinatorial library of single- and dual-ligand liposomes for in vitro and in vivo tumor targeting.
    Ran R; Wang H; Liu Y; Hui Y; Sun Q; Seth A; Wibowo D; Chen D; Zhao CX
    Eur J Pharm Biopharm; 2018 Sep; 130():1-10. PubMed ID: 29908938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.